Abiopharma

New Form 10-Q - Talkspace, Inc. Filed: 2025-05-09 AccNo: 0000950170-25-067550 Size: 7 MB

New Form ARS - Vireo Growth Inc. Filed: 2025-05-09 AccNo: 0001140361-25-018067 Size: 13 MB

Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast

New Form DEFA14A - Vireo Growth Inc. Filed: 2025-05-09 AccNo: 0001140361-25-018066 Size: 4 MB

New Form DEF 14A - Vireo Growth Inc. Filed: 2025-05-09 AccNo: 0001140361-25-018064 Size: 4 MB

Mirum Pharma - Volixibat Data from Mirum’s VANTAGE PBC Study Showcased at EASL

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Important Information for bluebird bio Stockholders to Tender Shares for Acquisition by Carlyle and SK Capital

Volixibat Data from Mirum’s VANTAGE PBC Study Showcased at EASL

New Form 10-Q - CVRx, Inc. Filed: 2025-05-09 AccNo: 0001558370-25-007077 Size: 5 MB

New Form 8-K - Vir Biotechnology, Inc. Filed: 2025-05-09 AccNo: 0001628280-25-024067 Size: 228 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - NOVO NORDISK A S Filed: 2025-05-09 AccNo: 0001171843-25-003007 Size: 171 KB

New Form 8-K - MeiraGTx Holdings plc Filed: 2025-05-09 AccNo: 0001558370-25-007074 Size: 193 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form S-8 - Claritev Corp Filed: 2025-05-09 AccNo: 0001793229-25-000112 Size: 309 KB

New Form 10-Q - Vireo Growth Inc. Filed: 2025-05-09 AccNo: 0001558370-25-007072 Size: 8 MB